Evidence map›Paper›PMID 38724792›Full record

ArticleAdvances in experimental medicine and biology2024

Nonprescription Treatment Options.

Taylor Edwards, Kayla Felix, Sandy Francois, Leah Cardwell, Zakiyyah Rice

Abstract read
PubMed Publisher
In one paragraph

Article in Advances in experimental medicine and biology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Taylor EdwardsOhio University Heritage College of Osteopathic Medicine, Athens, OH, USA.
Kayla FelixDepartment of Dermatology, Wake Forest University School of Medicine, Winston Salem, NC, USA.
Sandy FrancoisDepartment of Dermatology, Emory School of Medicine, Atlanta, GA, USA.
Leah CardwellDepartment of Dermatology, Wake Forest University School of Medicine, Winston Salem, NC, USA.
Zakiyyah RiceDepartment of Dermatology, Emory School of Medicine, Atlanta, GA, USA. zpressl@emory.edu.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The pathogenesis of atopic dermatitis (AD) is complex and multifactorial. However, recent advancements in the genetics and pathophysiology of AD suggest that epidermal barrier dysfunction is paramount in the development and progression of the condition (Boguniewicz M, Leung DYM, Immunol Rev 242(1):233-246, 2011). In addition to standard therapy for AD, there are a plethora of nonprescription treatment modalities which may be employed. Over-the-counter treatments for atopic dermatitis can come in the form of topical corticosteroids, moisturizers/emollients, and oral antihistamines. Though these treatments are beneficial, prescription treatments may be quicker acting and more efficacious in patients with moderate to severe disease or during flares. OTC agents are best used for maintenance between flares and to prevent progression of mild disease. Alternative and complementary treatments lack strong efficacy evidence. However, wet wraps, bleach baths, and other treatments appear to be promising when used in conjunction with conventional treatments. With the financial burden of atopic dermatitis ranging from 364 million to 3.8 billion dollars each year in the United States, we suspect this topic will gain further research attention.

Indexed as

Dermatitis, AtopicHistamine AntagonistsNonprescription DrugsAdrenal Cortex HormonesEmollientsHumansAdrenal Cortex HormonesEmollientsHistamine AntagonistsNonprescription DrugsAtopic dermatitisBleach bathsCeramidesCost of emollientsEmollientsEpidermal barrier dysfunctionHydrocortisoneNatural oilsNonprescription treatmentsPathogenesisTopical corticosteroidsWet wraps

Identifiers

PMID38724792

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.